SOURCE-LINKED STUDY SUMMARY
Why Do Patients with Type 2 Diabetes Lose Less Weight on GLP-1s? A Mathematical Modeling Analysis
Abstract summarizedQuality not appraised
- What was studied
- A mathematical model explored why people with type 2 diabetes may lose less weight during semaglutide treatment.
- Who / model studied
- Simulated human energy balance included diabetes-related changes in energy use and glucose lost in urine, with or without background SGLT2-inhibitor treatment. No participant count or simulation duration is stated.
- Studied dose & schedule
- Dose and schedule have not yet been extracted for this summary.
- What the study found
- The model suggested that lower energy use and reduced glucose loss in urine partly explain smaller weight reductions. It predicted the greatest attenuation with background SGLT2 inhibitors. These are model predictions, not a randomized treatment comparison.
- Limitations & context
- Study limitations were not stated in the abstract. Methodological quality has not been appraised.
Read summary source ↗ · Prepared 9/15/2026 · AI-assisted, source-based summary
Review record & corrections
Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.64898/2026.09.08.750112